The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.
Kinetoplastid parasites-trypanosomes and leishmanias-infect millions of humans and cause economically devastating diseases of livestock, and the few existing drugs have serious deficiencies. Benzoxaborole-based compounds are very promising potential novel anti-trypanosomal therapies, with candidates...
Main Authors: | Daniela Begolo, Isabel M Vincent, Federica Giordani, Ina Pöhner, Michael J Witty, Timothy G Rowan, Zakaria Bengaly, Kirsten Gillingwater, Yvonne Freund, Rebecca C Wade, Michael P Barrett, Christine Clayton |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-09-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1007315 |
Similar Items
-
Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs.
by: Federica Giordani, et al.
Published: (2020-11-01) -
Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei
by: Albina Waithaka, et al.
Published: (2022-12-01) -
Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei.
by: Pieter C Steketee, et al.
Published: (2018-05-01) -
Anti-parasitic benzoxaboroles are ineffective against Theileria parva in vitro
by: Pieter C. Steketee, et al.
Published: (2023-12-01) -
Benzoxaboroles—Novel Autotaxin Inhibitors
by: Kristina Kraljić, et al.
Published: (2019-09-01)